Found: 11
Select item for more details and to access through your institution.
The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3.
- Published in:
- Pflügers Archiv: European Journal of Physiology, 2014, v. 466, n. 3, p. 517, doi. 10.1007/s00424-013-1335-8
- By:
- Publication type:
- Article
Interaction of Masitinib with Organic Cation Transporters.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14189, doi. 10.3390/ijms232214189
- By:
- Publication type:
- Article
Transport Mechanisms and Their Pathology-Induced Regulation Govern Tyrosine Kinase Inhibitor Delivery in Rheumatoid Arthritis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0052247
- By:
- Publication type:
- Article
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0177146
- By:
- Publication type:
- Article
Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13—Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5880, doi. 10.3390/cancers13235880
- By:
- Publication type:
- Article
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2841, doi. 10.3390/cancers13112841
- By:
- Publication type:
- Article
Animal Safety, Toxicology, and Pharmacokinetic Studies According to the ICH S9 Guideline for a Novel Fusion Protein tTF-NGR Targeting Procoagulatory Activity into Tumor Vasculature: Are Results Predictive for Humans?
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3536, doi. 10.3390/cancers12123536
- By:
- Publication type:
- Article
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1488, doi. 10.3390/cancers12061488
- By:
- Publication type:
- Article
Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0229271
- By:
- Publication type:
- Article
Role of transporters in the distribution of platinum-based drugs.
- Published in:
- Frontiers in Pharmacology, 2015, v. 6, p. 1, doi. 10.3389/fphar.2015.00085
- By:
- Publication type:
- Article